TY - JOUR
T1 - The mutagenicity of chemically synthesised metabolites of 16,17-dihydrocyclopenta[a]phenanthrene and its carcinogenic 11-methyl homologue.
AU - Papaparaskeva-Petrides, Christiana
AU - Ioannides, Costas
AU - Boyd, Gary
AU - Young, Robert J
AU - Harvey, Ronald G
AU - Coombs, Maurice M
PY - 1993/7
Y1 - 1993/7
N2 - Putative synthetic metabolites of the hydrocarbon 16, 17-dihydro-15H-cyclopenta[α]phenanthrene and its carcinogenic 11-methyl analogue, namely trans-3, 4-dihydroxy- 3, 4, 16, 17-tetrahydro-15H-cyclopenta[α]phenanthrene and its 11-methyl derivative, together with the four associated trans-3, 4-dihydroxy-syn- and anti-1, 2-epoxides, were assayed for mutagenicity in the Ames test with Salmonella typhimurium TA100 with and without microsomal activation. The hydrocarbons were weakly mutagenic and the 3, 4-diols were more strongly so, but all required activation to express their mutagenic potential. All four diol-epoxides were much more potent mutagens, even in the absence of activation. This is in accord with the anticipated metabolic activation sequence: hydrocarbons — 3, 4-diols — 3, 4-diol-1, 2-epoxides.
AB - Putative synthetic metabolites of the hydrocarbon 16, 17-dihydro-15H-cyclopenta[α]phenanthrene and its carcinogenic 11-methyl analogue, namely trans-3, 4-dihydroxy- 3, 4, 16, 17-tetrahydro-15H-cyclopenta[α]phenanthrene and its 11-methyl derivative, together with the four associated trans-3, 4-dihydroxy-syn- and anti-1, 2-epoxides, were assayed for mutagenicity in the Ames test with Salmonella typhimurium TA100 with and without microsomal activation. The hydrocarbons were weakly mutagenic and the 3, 4-diols were more strongly so, but all required activation to express their mutagenic potential. All four diol-epoxides were much more potent mutagens, even in the absence of activation. This is in accord with the anticipated metabolic activation sequence: hydrocarbons — 3, 4-diols — 3, 4-diol-1, 2-epoxides.
U2 - 10.1093/mutage/8.4.307
DO - 10.1093/mutage/8.4.307
M3 - Article
SN - 1464-3804
VL - 8
SP - 307
EP - 310
JO - Mutagenesis
JF - Mutagenesis
IS - 4
ER -